KHB Highlights the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at MEDICA 2025
XI'AN, China, Nov. 19, 2025 /PRNewswire/ -- Shanghai Kehua Bio-engineering Co., Ltd. (KHB), a global provider of in-vitro diagnostic (IVD) solutions, is showcasing its latest compact chemiluminescence platform—the Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer—at MEDICA 2025, one o...
KHB Showcases the Enhanced FOCUS PEGASUS MF200 -- Redefining Efficiency in Veterinary Diagnostics
XI'AN, China, Nov. 13, 2025 /PRNewswire/ -- Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in veterinary point-of-care testing (POCT) solutions, presents the enhanced FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer — a next-generation system ...
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit
SHANGHAI, Oct. 11, 2023 /PRNewswire/ -- Shanghai Kehua Bio-engineering
KHB Shanghai Kehua Bio-Engineering Acquires the Italian Technogenetics
MILAN, Dec. 21, 2015 /PRNewswire/ -- KHB Shanghai Kehua Bio-Engineering Co., Ltd listed on the Shenzhen Stock Exchange (Stock Code 002022), one of the leading in vitro diagnostic (IVD) products developers inChina, announced today the closure of the deal with Technogenetics, innovative immunodiagn...
